Mazagon Dock Shipbuilders Ltd. (MDL) shares witnessed a significant surge of over 6% after global brokerage firm JPMorgan initiated coverage with a “Neutral” rating and a target price of ₹4,248. The recent spike highlights growing investor interest in the defense sector, driven by robust growth prospects and favorable government policies.

Mazagon Dock Shipbuilders’ stock has experienced significant volatility, with its price hitting a high of ₹4,434 and a low of ₹4,156.70 today, while its 52-week low was ₹1,795.40. Despite the fluctuations, the recent corrections in stock prices across the sector have created attractive entry points for investors who are looking at long-term growth potential in the defense space.

As of 9:54 am, Emcure Pharmaceuticals shares were trading 6.00% higher at Rs 4,426.00 on the NSE.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.

TOPICS: Mazagon Dock